| Thursday 27 October |
| 13:00 - 13:30 |
Registration |
| 13:30 - 13:45 |
Welcome: Presentation of the two Associations |
M.Piepoli, P. Ponikowski |
|
Session 1: Introduction: what are we talking about? |
Chairpersons: K. Dickstein, M Piepoli |
| 13:45-14:05 |
From cardiac dysfunction to heart failure symptoms (patho-physiology of heart failure) |
P. Ponikowski |
| 14:05-14:25 |
Exercise intolerence in systolic and diastolic dysfunction |
J.-P. Schmid |
| 14:25-14:45 |
Optimal pharmacologic and device therapy |
K. Dickstein |
| 14:45-15:00 |
Panel discussion |
|
| 15:00-15:20 |
Coffee break |
|
|
Session 2: Long term management of heart failure |
Chairpersons: K.Dickstein, P. Ponikowski |
| 15:20-15:40 |
Cardiac resynchronization therapy: from treatment to prevention? |
M. Wilhelm |
| 15:40-16:00 |
Benefits of cardiac rehabilitation in CHF management |
M. Piepoli |
| 16:00-16:20 |
Overcoming barriers to patient adherence in CHF management |
C. Deaton |
| 16:20-16:40 |
Panel discussion |
|
| 16:40-17:00 |
Coffee break |
|
| |
Session 3: “Practical issues of exercise training in HF –warming up the audience and speakers”: which programme for which patient? |
Chairpersons: M. Piepoli, V Conraad |
| 17:00-17:20 |
In-patient cardiac rehabilitation |
U. Corrà |
| 17:20-17:40 |
Out-patient, hospital based – cardiac rehabilitation |
J.-P. Schmid |
| 17:40-18:00 |
Home-based cardiac rehabilitation |
C. Deaton |
| 18:00-18.30 |
Panel discussion |
|
| |
| Friday 24 September |
| |
Session 4: Assessment of exercise capacity |
Chairpersons: K. Dickstein, P. Ponikowski |
| 8:30-8:50 |
Relation between LV dysfunction and exercise capacity |
M. Piepoli |
| 8:50-9:20 |
How to assess exercise capacity in HF patients: role of the 6-minutes walk test |
V. Conraads |
| 9:10-9:30 |
CPET: Differential assessment of exercise intolerance: Central – pulmonary or muscular limitation |
J.-P. Schmid |
| 9:30-9:50 |
CPET: Parameters for risk stratification |
U. Corrà |
| 9:50-10:10 |
Panel Discussion |
|
| 10:10-10:45 |
Coffee break |
|
| |
Session 5: How to session (Transmission into main auditorium) |
Chairpersons: M. Piepoli, V. Conraads |
| 10:45-12:30 |
How to perform cardiopulmonary exercise testing:
- healthy subject
- typical CHF patients with limited exercise tolerance |
M. Wilhelm, J.-P. Schmid |
| 12:30-14:00 |
Lunch |
|
| |
Session 6: Exercise training: Definition and modalities |
Chairpersons: U. Corrà, E. Piotrowicz |
| 14:00-14:30 |
Exercise training: Definitions, indications, contra-indication |
K. Dickstein |
| 14:30-15:00 |
Endurance training (interval vs steady state) |
J.-P. Schmid |
| 15:00-15:30 |
Resistance/strength training of peripheral and respiratory muscle |
V. Conraads |
| 15:30-16:00 |
Discussion |
|
| 16:00-16:30 |
Coffee break |
|
| |
Session 7: How to session (Transmission into main auditorium)
Exercise training session: cycle exercise, resistance/strength exercise, mobility, coordination, respiratory training |
Chairpersons: V. Conraads, U. Corrà |
| 16:30-17:00 |
Strength training |
|
| 17:00-17:30 |
Respiratory training |
|
| 17.30-18:00 |
Endurance training |
|
| 18:00-18:30 |
Mobility coordination |
|
| 18:45 |
Departure for dinner |
|
| |
| Saturday 29 October |
| |
Session 8: Exercise training in patients with an ICD/CRT |
Chairpersons: H. Saner, E. Piotrowicz |
| 8:30-8:50 |
What is special in training with ICD/CRT patients |
V. Conraads |
| 8:50-9:10 |
Risk of arrhythmias & shocks during training |
M. Wilhelm |
| 9:10-9:50 |
How to approach patient’ concerns about an ICD |
D. Frizelle |
| 9:50-10:10 |
Coffee break |
|
| |
Session 9: Long-term management: a comprehensive approach |
Chairpersons: M. Wilhelm, C. Deaton |
| 10:10-10:30 |
Weight and lipid management in the CHF patient |
M. Piepoli |
| 10:30-10:50 |
Psychological problems and management |
D. Frizelle |
| 10.50-11:10 |
How to overcome barriers to implement: Monitoring and role of telemedicine |
E. Piotrowicz |
| 11:10-11:30 |
Coffee break |
|
| |
Session 10: How to monitor efficacy |
Chairpersons: M. Piepoli, E. Piotrowicz |
| 11:30-11:50 |
Parameters of exercise capacity or echocardiography |
J.-P. Schmid |
| 11:50-12:10 |
Biomarkers |
M. Martinelli |
| 12:10-12:30 |
Audit and quality assurance |
H. Saner |
| 12:30-12:50 |
Panel Discussion |
|
| 12:50-13:10 |
Summary and Conclusions |
J-P. Schmid, M. Piepoli |